Cowen Starts Sophia Genetics SA (SOPH) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
Go back to Cowen Starts Sophia Genetics SA (SOPH) at Outperform
August 17, 2021 4:27 AM EDT
(Updated - August 17, 2021 4:43 AM EDT)
Credit Suisse analyst Katie Tryhane initiates coverage on Sophia Genetics SA (NASDAQ: SOPH) with a Outperform rating and a price target of $22.00.
The analyst comments "SOPH is a healthcare technology company offering a decentralized software platform that leverages... More
August 17, 2021 4:20 AM EDT
JPMorgan analyst Tycho W. Peterson initiates coverage on Sophia Genetics SA (NASDAQ: SOPH) with a Overweight rating and a price target of $23.00.
For an analyst ratings summary and ratings history on Sophia Genetics SA... More
August 17, 2021 3:31 AM EDT
(Updated - August 17, 2021 4:41 AM EDT)
Morgan Stanley analyst Tejas Savant initiates coverage on Sophia Genetics SA (NASDAQ: SOPH) with a Overweight rating and a price target of $24.00.
The analyst comments "Riding on the coattails of healthcare digitization, SOPHs differentiated... More
